Martin Hutchings Selected Research

Deoxyglucose (2 Deoxy D glucose)

6/2012	Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
4/2008	Early interim PET scan in Hodgkin lymphoma: where do we stand?
8/2007	Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.
1/2006	FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Hutchings Research Topics

Disease

30	Hodgkin Disease (Hodgkin's Disease) 04/2024 - 10/2004
15	Lymphoma (Lymphomas) 01/2023 - 04/2008
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022 - 04/2009
6	Neoplasms (Cancer) 01/2024 - 09/2012
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2024 - 03/2018
4	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023 - 01/2021
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2024 - 05/2009
3	Residual Neoplasm 12/2023 - 08/2007
3	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 12/2005
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2023 - 05/2015
3	Disease Progression 01/2023 - 03/2018
3	Cardiotoxicity 10/2020 - 03/2018
2	Infections 05/2024 - 10/2023
2	Cytokine Release Syndrome 01/2024 - 12/2022
2	Febrile Neutropenia 01/2022 - 11/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2024
1	Tonsillar Neoplasms 12/2023
1	Exanthema (Rash) 12/2023
1	Thrombocytopenia (Thrombopenia) 12/2023
1	Neutropenia 12/2023
1	Colitis 12/2023
1	COVID-19 10/2023
1	Hairy Cell Leukemia 01/2023
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Diarrhea 11/2021
1	Hyperbilirubinemia 11/2021
1	Infertility (Sterility) 11/2021
1	Fever (Fevers) 01/2021
1	Ototoxicity 01/2021
1	Heart Failure 03/2018
1	Cardiomyopathies (Cardiomyopathy) 03/2018
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2018

Drug/Important Bio-Agent (IBA)

12	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 08/2007
10	Dacarbazine (DIC)FDA LinkGeneric 11/2023 - 08/2007
10	Vinblastine (Vinblastine Sulfate)FDA Link 11/2023 - 08/2007
9	Bleomycin (Blenoxane)FDA LinkGeneric 04/2024 - 08/2007
9	Brentuximab VedotinIBA 10/2023 - 01/2019
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021 - 04/2009
5	Rituximab (Mabthera)FDA Link 12/2023 - 05/2015
4	Deoxyglucose (2 Deoxy D glucose)IBA 06/2012 - 01/2006
3	Bispecific AntibodiesIBA 01/2024 - 06/2023
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2019
2	ibrutinibIBA 05/2024 - 03/2018
2	venetoclaxIBA 12/2023 - 11/2021
2	Lenalidomide (CC 5013)FDA Link 12/2023 - 03/2018
2	obinutuzumabIBA 12/2023 - 12/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2022
2	glofitamabIBA 12/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 12/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2019
1	AlbuminsIBA 04/2024
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2024
1	Alanine Transaminase (SGPT)IBA 12/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023
1	Bendamustine Hydrochloride FDA Link 12/2023
1	parsaclisibIBA 12/2023
1	Etoposide (VP 16)FDA LinkGeneric 11/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023
1	Prednisone (Sone)FDA LinkGeneric 11/2023
1	Procarbazine (Matulane)FDA Link 11/2023
1	Vincristine (Oncovin)FDA LinkGeneric 11/2023
1	trametinibIBA 01/2023
1	dabrafenibIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Vitamin D FDA LinkGeneric 12/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	ProteomeIBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	RO6870810IBA 11/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2021
1	EnzymesIBA 01/2021
1	CytokinesIBA 01/2021
1	Rubidium-82IBA 10/2020
1	Adenosine (Adenocard)FDA LinkGeneric 10/2020
1	FluorineIBA 09/2020
1	3-Iodobenzylguanidine (Iobenguane)IBA 03/2018
1	AnthracyclinesIBA 03/2018
1	Antineoplastic Agents (Antineoplastics)IBA 03/2018
1	AFM13IBA 06/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2015

Therapy/Procedure

18	Therapeutics 10/2023 - 10/2004
13	Drug Therapy (Chemotherapy) 04/2024 - 01/2006
5	Radiotherapy 11/2023 - 03/2007
3	Immunotherapy 01/2024 - 06/2015
2	Stem Cell Transplantation 05/2024 - 01/2020
2	Salvage Therapy 01/2021 - 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2024
1	Precision Medicine 10/2023
1	Transplantation 01/2022
1	Operative Surgical Procedures 07/2016
1	Neoadjuvant Therapy 09/2012